Brief: Iambic Announces Collaboration With Takeda To Advance AI-Driven Design Of Small Molecules

Takeda Pharmaceutical

09/02/2026 13:00

Feb 9 (Reuters) - IAMBIC:

IAMBIC: ANNOUNCES COLLABORATION WITH TAKEDA TO ADVANCE AI-DRIVEN DESIGN OF SMALL MOLECULES

IAMBIC: TO RECEIVE UPFRONT, RESEARCH COST, TECHNOLOGY ACCESS PAYMENTS; ELIGIBLE FOR SUCCESS-BASED PAYMENTS THAT COULD EXCEED $1.7 BILLION

IAMBIC: TO PROVIDE TAKEDA ACCESS TO NEURALPLEXER

IAMBIC: ALSO ELIGIBLE TO RECEIVE ROYALTIES ON NET SALES OF ANY PRODUCTS GENERATED FROM COLLABORATION

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))